Related Experiment Videos
Non-HLA immunological factors in eighteen HLA-identical renal allografts
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cyclooxygenase-2 inhibitor-associated minimal-change disease.
Clinical nephrology·2005
Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome.
Pediatric neurology·2001
Economic, social, racial and age-related considerations in dialysis and transplantation.
Current opinion in nephrology and hypertension·1995
Ethics in organ donation: contrasts in two cultures.
Transplantation proceedings·1991
Secondary procedures for A-V fistula failure.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association·1983
Plasmapheresis induced recovery from renal failure in mesangiocapillary glomerulonephritis of acute onset.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association·1983
Prednisone-induced increase of proteinuria in patients with a nephrotic syndrome.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association·1983
Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidism.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association·1983
pH--dependence of phosphate absorption in rat renal proximal tubule.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association·1983
Three years experience with a very low nitrogen diet supplemented with essential amino acids and keto-analogues in the treatment of chronic uraemia.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association·1983
Efficacy of Remimazolam for Anesthesia in Patients Undergoing Renal Allograft Transplantation: A Randomized Controlled Trial.
Drug design, development and therapy·2026
A Case of Graft-Versus-Host Disease in a Liver Transplant Recipient Receiving an HCV NAT Positive Organ: Does HCV NAT Matter?
Transplantation proceedings·2026